J & J | Motrin | McNeil | Defective Drug

NATIONAL – According to USA Today (10/5) editorializes, “Last year, when J&J faced what should have been a relatively minor problem, executives forgot to read their own textbook.” J&J “discovered in late 2008 that some Motrin tablets, made by its McNeil division, were not dissolving properly, possibly affecting their potency. So did executives publicly announce the problem and recall the defective product?”
USA Today continues, “Hardly. Instead, J&J hired a contractor that quietly dispatched workers to retailers to buy up thousands of the Motrin vials. … In other words, the goal was to hide the problem.”
Now J&J “could use some extra-strength Tylenol for a public relations migraine it richly deserves.”

Leave a Reply

Your email address will not be published. Required fields are marked *